Neurogene Inc.
NGNE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404644
In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 2 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Neurogene Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q1 2023
- Shares held
- 17.3M
- +2.23M (+14.8%) vs. Q1 2023
- Total value
- $14.3M
- +$3.80M (+36.1%) vs. Q1 2023
- New holders
- 5
- 7 more added
- Sold out
- 8
- 9 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NGNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $544.4M |
| Q1 2026 | 96 | $342.0M |
| Q4 2025 | 93 | $340.4M |
| Q3 2025 | 88 | $265.2M |
| Q2 2025 | 83 | $230.1M |
| Q1 2025 | 86 | $192.8M |
| Q4 2024 | 89 | $367.8M |
| Q3 2024 | 86 | $581.1M |
| Q2 2024 | 66 | $482.7M |
| Q1 2024 | 60 | $617.3M |
| Q4 2023 | 35 | $179.0M |
| Q3 2023 | 31 | $14.4M |
| Q2 2023 | 36 | $14.3M |
| Q1 2023 | 39 | $10.5M |
| Q4 2022 | 46 | $8.66M |
| Q3 2022 | 52 | $12.0M |
| Q2 2022 | 64 | $21.4M |
| Q1 2022 | 81 | $46.3M |
| Q4 2021 | 80 | $118.8M |
| Q3 2021 | 85 | $187.1M |
| Q2 2021 | 82 | $248.8M |
| Q1 2021 | 82 | $341.9M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Neurogene Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 592 | $0 | 0.00% | +389+191.6% | Added |
| Barclays PLC | 163 | $135 | 0.00% | −5,127−96.9% | Reduced |
| National Bank of Canada | 175 | $144 | 0.00% | +175 | New |
| JPMorgan Chase & Co | 223 | $185 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 925 | $768 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 1,000 | $830 | 0.00% | +1,000 | New |
| UBS Group AG | 1,100 | $913 | 0.00% | −13,805−92.6% | Reduced |
| Advisor Group Holdings, Inc. | 1,500 | $1.25K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,504 | $1.25K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 1,555 | $1.29K | 0.00% | −348−18.3% | Reduced |
| Wells Fargo & Company | 8,244 | $6.84K | 0.00% | +11+0.1% | Added |
| Bank of New York Mellon Corp | 14,372 | $11.9K | 0.00% | 00.0% | Unchanged |
| Simon Quick Advisors, LLC | 23,428 | $19.4K | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 23,749 | $19.7K | 0.02% | 00.0% | Unchanged |
| US Bancorp | 44,346 | $36.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 47,891 | $39.8K | 0.00% | +47,891 | New |
| HighTower Advisors, LLC | 48,409 | $40.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 69,541 | $57.7K | 0.00% | −224−0.3% | Reduced |
| Alta Fundamental Advisers LLC | 89,702 | $74.5K | 0.04% | +89,702 | New |
| Privium Fund Management (UK) Ltd | 117,200 | $94.9K | 0.07% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 119,966 | $99.6K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 122,556 | $101.7K | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 136,675 | $113.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 184,500 | $153.1K | 0.00% | −49,700−21.2% | Reduced |
| Two Sigma Investments, LP | 211,194 | $175.3K | 0.00% | −15,500−6.8% | Reduced |
| Geode Capital Management, LLC | 301,057 | $249.9K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 483,948 | $401.7K | 0.00% | −80,527−14.3% | Reduced |
| Millennium Management LLC | 609,651 | $506.0K | 0.00% | −167,497−21.6% | Reduced |
| Morgan Stanley | 821,972 | $682.2K | 0.00% | +3070.0% | Added |
| Western Standard LLC | 860,882 | $714.5K | 0.62% | +860,882 | New |
| Renaissance Technologies LLC | 937,223 | $778.0K | 0.00% | +22,610+2.5% | Added |
| Vanguard Group Inc | 1,010,812 | $839.0K | 0.00% | −5,484−0.5% | Reduced |
| Bank of America Corp | 1,160,016 | $962.8K | 0.00% | +3,171+0.3% | Added |
| Redmile Group, LLC | 2,912,228 | $2.42M | 0.09% | +1,064,628+57.6% | Added |
| Lynx1 Capital Management LP | 3,094,554 | $2.57M | 1.68% | +666,231+27.4% | Added |
| Baker Bros. Advisors LP | 3,821,740 | $3.17M | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Endurance Wealth Management, Inc. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,991−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,441−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −6,709−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −622−100.0% | Sold out |